Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DB25FTBKF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,293
Award facts
- Contract value 100% obligated
- $22,292.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $22,292.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Cosentyx (secukinumab) 300mg dose in 2-pen/ml formulation. This is a competitive award with no set-aside designation, with a completion date of September 19, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills pharmaceutical needs across the Defense Health Agency and other government healthcare systems through its extensive DLA contract portfolio. Cosentyx is a specialty biologic medication used in the treatment of various inflammatory and autoimmune conditions, representing the type of specialized pharmaceutical commodities the company regularly supplies to support military medical operations. AmerisourceBergen's consistent award history through open competition and its significant prime vendor status with DLA Troop Support Medical demonstrate the company's capability to meet federal pharmaceutical procurement requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FTBKF?
SPE2DB25FTBKF was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 18, 2025.
How much is contract SPE2DB25FTBKF worth?
The government has obligated $22,293 on SPE2DB25FTBKF.
Is contract SPE2DB25FTBKF an order under another contract?
Yes. SPE2DB25FTBKF is a delivery order under SPE2DB25D3202, an indefinite delivery contract.
Was contract SPE2DB25FTBKF competed?
The extent of competition for SPE2DB25FTBKF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award